Ruxolitinib–oHSV Therapy Maps Sarcoma Immunity
2026-09-07
The reference study introduces a 46-color spectral flow cytometry panel to characterize lymphoid and myeloid responses after combined Ruxolitinib and oncolytic herpes simplex virus treatment in murine malignant peripheral nerve sheath tumors. The combination was associated with activated germinal center B cells and cytokine-producing CD4 T-cell states, showing how high-dimensional immune profiling can reveal treatment effects missed by conventional flow cytometry.
Melatonin-Tuned mRNA LNPs for Pulmonary Fibrosis
2026-09-05
The reference study presents melatonin as both an antioxidant cargo component and a membrane-level modulator of lipid nanoparticles, improving cytosolic Nrf2 mRNA delivery to mesenchymal stem cells. In epithelial injury and bleomycin-induced pulmonary fibrosis models, the resulting engineered cells showed stronger cytoprotective and antifibrotic activity, although important translational questions remain.
Standardized Whole-Blood Stimulation and Immunometabolism
2026-09-04
Zhao and colleagues present a standardized whole-blood stimulation protocol for testing how metabolic interventions reshape human immune responses. By combining diverse innate immune stimuli, metabolic inhibitors, and cytokine measurements, the workflow distinguishes pathway-selective effects from generalized immune suppression and offers a reproducible platform for cohort studies.
Diethylmaleate: A Precision Redox Perturbation Tool
2026-09-04
Diethylmaleate is a versatile intracellular glutathione modulator for oxidative stress, redox regulation, and toxicology research. This guide explains how recent GST-resistance findings can improve causal assay design while clarifying its limitations across cellular and organismal models.
BCA Protein Quantification Kit K4102 Guide
2026-09-03
The BCA Protein Quantification Kit K4102 measures total protein in dilute biochemical samples, cell lysates, and many detergent-containing preparations across 0.5–20 µg/mL. It is intended for scientific research workflows such as sample normalization and is not for diagnostic, clinical, or medical testing.
AICAR and the AMPK–Mitophagy Translation Gap
2026-09-03
A mechanistic and strategic guide to using AICAR as a cell-permeable AMPK perturbation tool in metabolic disease research, with particular focus on skeletal muscle, mitophagy, inflammation, and translational validation.
BMS 599626 Dihydrochloride in Mechanistic Assays
2026-09-02
BMS 599626 dihydrochloride is a selective EGFR and ErbB2 inhibitor for dissecting receptor signaling, proliferation, and tumor-model responses. This article presents an assay-centered framework that connects kinase perturbation with interpretable, machine-learning-guided senescence research.
From E6 Inactivation to Senescence Readouts
2026-09-02
Targeted HPV-16 E6 inhibition shows how restoring p53 can push cancer cells toward apoptosis or senescence. For translational researchers, reliable SA-β-Gal measurement is essential for separating a mechanistic hypothesis from a defensible treatment-response claim.
Epidermal Growth Factor: Assay Workflows
2026-09-01
Build more interpretable proliferation, migration, spheroid, and oncology assays with recombinant human EGF as a defined growth-factor input. This guide connects product handling to the MYC-driven triple-negative breast cancer screen while separating validated biology from practical assay recommendations.
Bicinchoninic Acid Assay: K4102 Guide
2026-09-01
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports low-concentration total-protein measurement in dilute biochemical samples, cell lysates, and many detergent-containing preparations. It is intended for scientific research workflows and should not be used for diagnostic, clinical, or medical testing.
Live-Dead Bacterial Staining Kit for Nanomaterials
2026-08-31
Translate membrane damage into rapid, single-cell viability data for antimicrobial screening. This workflow shows how to apply dual-fluorescence staining to Fe3O4@ZIF-8 research while avoiding the common mistake of treating membrane compromise as a complete substitute for culturability.
Pentoxifylline and Preterm Monocyte Hyperinflammation
2026-08-31
Schüller et al. developed an age-comparative whole-blood model to examine how pentoxifylline suppresses LPS-induced monocyte activation in preterm infants, term infants, and adults. The study links reduced cytokine production and phagocytosis to lower cellular and transcriptional TLR4 activity, while revealing age-dependent effects on monocyte markers and IL-10.
Telmisartan: A Mechanistic Control for Cardiac Hypertrophy
2026-08-30
Telmisartan is an angiotensin II receptor antagonist that can serve as a mechanistic control in cardiac hypertrophy and cardiovascular disease research. This article explains how to distinguish AT1R-proximal effects from RIP3/CaMKII signaling and design more informative pathway assays.
Sodium Selenite Suppresses Cervical Cancer Metabolism
2026-08-29
The reference study shows that sodium selenite suppresses cervical cancer growth by increasing reactive oxygen species and disrupting AKT/mTOR/HIF-1α control of glucose metabolic reprogramming. Its combination of 2-NBDG-based uptake measurements, molecular profiling, rescue experiments, and xenograft validation provides a mechanistic framework for connecting altered glucose use with tumor progression.
Synthetic DEFB1 mRNA Against Cryptosporidiosis
2026-08-28
The reference study shows that synthetic DEFB1 mRNA can transiently increase β-defensin 1 production in HCT-8 intestinal cells and reduce Cryptosporidium parvum burden by approximately 80% without detectable cytotoxicity. Its main contribution is a host-directed mRNA strategy that links rapid gene delivery with functional protection against an enteric parasite in vitro.
560 records 6/38 page Previous Next First page 上5页 678910 下5页 Last page